Prions food and drug safety /

Por Kitamoto, Tetsuyuki., International Symposium of Prion Diseases for Food and Drug Safety
Publicado em 2005

Anaesthesia, pain, intensive care and emergency medicine A.P.I.C.E. : proceedings of the 19th...

Por Postgraduate Course in Critical Care Medicine, Gullo, Antonino.
Publicado em 2005

Addressing Unmet Medical Needs in Type 2 Diabetes: A Narrative Review of Drugs under Development

Por Mittermayer, Friedrich, Caveney, Erica, Oliveira, Claudia De, Gourgiotis, Loukas, Puri, Mala, Tai, Li-Jung, J, Rick Turner
Publicado no Curr Diabetes Rev (2015)

Pharmacokinetic drug interactions in liver disease: An update

Por Palatini, Pietro, De Martin, Sara
Publicado no World J Gastroenterol (2016)

Diabetes: glycaemic control in type 2 (drug treatments)

Por Gorter, Kees J, van de Laar, Floris Alexander, Janssen, Paul G H, Houweling, Sebastian T, Rutten, Guy E H M
Publicado em 2012

Application of liposomes in drug development — focus on gastroenterological targets

Por Zhang, Jian-Xin, Wang, Kun, Mao, Zheng-Fa, Fan, Xin, Jiang, De-Li, Chen, Min, Cui, Lei, Sun, Kang, Dang, Sheng-Chun
Publicado em 2013

Safety aspects of protease inhibitors for chronic hepatitis C: adverse events and drug-to-drug interactions

Por Rosângela Teixeira, Yone de Almeida Nascimento, Déborah Crespo

Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery

Por Paola eImbrici, Antonella eLiantonio, Giulia Maria eCamerino, Michela eDe Bellis, Claudia eCamerino, Antonietta eMele, Arcangela eGiustino, Sabata ePierno, Annamaria eDe Luca, Domenico eTricarico, Jean-Francois eDesaphy, Diana eConte
Publicado em 2016-05-01

The Kidney in Type 2 Diabetes Therapy

Por Lambers Heerspink, Hiddo J., de Zeeuw, Dick
Publicado em 2011

Alzheimer’s Disease Drug Development in 2008 and Beyond: Problems and Opportunities

Por Becker, Robert E., Greig, Nigel H.
Publicado em 2008

Effect of Psychotropic Drugs on Development of Diabetes Mellitus in Patients With Alzheimer's Disease

Por Chang, Ki Jung, Hong, Chang Hyung, Lee, Yunhwan, Lee, Kang Soo, Roh, Hyun Woong, Back, Joung Hwan, Jung, Young Ki, Lim, Ki Young, Noh, Jai Sung, Kim, Hyun Chung, Choi, Seong Hye, Kim, Seong Yoon, Na, Duk L., Seo, Sang Won, Lee, Soojin, Son, Sang Joon
Publicado no Medicine (Baltimore) (2015)

Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease

Por Federico, Alessandro, Zulli, Claudio, de Sio, Ilario, Del Prete, Anna, Dallio, Marcello, Masarone, Mario, Loguercio, Carmela
Publicado no World J Gastroenterol (2014)

Insulin and Autophagy in Neurodegeneration

Por Natália Prudente de Mello, Ana Maria Orellana, Caio Henrique Mazucanti, Geovanni de Morais Lima, Cristoforo Scavone, Elisa Mitiko Kawamoto
Publicado em 2019-05-01

Progressive cellular immune impairment leading to development of AIDS: two-year prospective study of HIV infection in drug addicts.

Por Fernandez-Cruz, E, Fernandez, A M, Gutierrez, C, Garcia-Montes, M, de la Morena, M T, Rodriguez-Villanueva, J, Longo, N, Zabay, J M
Publicado em 1988

IS6110 Restriction Fragment Length Polymorphism Typing of Drug-resistant Mycobacterium tuberculosis Strains from Northeast South Africa

Por Green, Ezekiel, Obi, Lawrence C., Okoh, Anthony I., Nchabeleng, Maphoshane, Villiers, Babsie E. De, Letsoalo, Tomas, Hoosen, Anwar A., Bessong, Pascal O., Ndip, Roland N.
Publicado em 2013

The impact of lipocalin-type-prostaglandin-D-synthase as a predictor of kidney disease in patients with type 2 diabetes

Por Bacci, Marcelo Rodrigues, Cavallari, Marina Romera, de Rozier-Alves, Ross Martin, Alves, Beatriz da Costa Aguiar, Fonseca, Fernando Luiz Affonso
Publicado no Drug Des Devel Ther (2015)

Caenorhabditis elegans as a Model System for Studying Drug Induced Mitochondrial Toxicity

Por de Boer, Richard, Smith, Ruben L., De Vos, Winnok H., Manders, Erik M. M., Brul, Stanley, van der Spek, Hans
Publicado no PLoS One (2015)

Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures

Por Sablón-Carrazana, Marquiza, Fernández, Isaac, Bencomo, Alberto, Lara-Martínez, Reyna, Rivera-Marrero, Suchitil, Domínguez, Guadalupe, Pérez-Perera, Rafaela, Jiménez-García, Luis Felipe, Altamirano-Bustamante, Nelly F., Diaz-Delgado, Massiel, Vedrenne, Fernand, Rivillas-Acevedo, Lina, Pasten-Hidalgo, Karina, Segura-Valdez, María de Lourdes, Islas-Andrade, Sergio, Garrido-Magaña, Eulalia, Perera-Pintado, Alejandro, Prats-Capote, Anaís, Rodríguez-Tanty, Chryslaine, Altamirano-Bustamante, Myriam M.
Publicado no PLoS One (2015)

Anti-diabetic Agents in Type 2 Diabetes: A Review of New Data Presented and Discussed on the EASD meeting in Rome, 2008

Por de Valk, Harold W.
Publicado em 2008

A human liver microphysiology platform for investigating physiology, drug safety, and disease models

Por Vernetti, Lawrence A, Senutovitch, Nina, Boltz, Robert, DeBiasio, Richard, Ying Shun, Tong, Gough, Albert, Taylor, D Lansing
Publicado no Exp Biol Med (Maywood) (2015)